Neuropsychiatric symptoms as early indicators of brain tumors

  • 0Department of Morpho-Functional Sciences I, Grigore T. Popa University Medicine and Pharmacy, Iasi, Romania.

|

|

Summary

This summary is machine-generated.

Anxiety, depression, and cognitive changes may serve as early biomarkers for brain tumors. These symptoms, linked to tumor characteristics, can persist even after tumor removal, highlighting their complex relationship with brain cancer.

Area Of Science

  • Neuro-oncology
  • Psychiatry
  • Cognitive Neuroscience

Background

  • Brain tumors are rare, heterogeneous malignancies with significant mortality.
  • Early detection of brain tumors is crucial for improving patient prognosis.
  • Psychological and cognitive changes are frequently observed in cancer patients.

Purpose Of The Study

  • To investigate anxiety, depression, and cognitive changes as potential early biomarkers for brain tumors.
  • To analyze the presentation of these changes across different tumor types.
  • To explore the relationship between these changes and tumor characteristics.

Main Methods

  • Review of clinical presentations of anxiety, depression, and cognitive changes in patients with various brain tumor types.
  • Correlation analysis between psychological/cognitive symptoms and tumor location, size, and type.
  • Assessment of symptom persistence post-tumor removal.

Main Results

  • Anxiety, depression, and cognitive deficits are observed in brain tumor patients.
  • Cognitive changes are often linked to tumor location, size, and type, and correlate with anxiety and depression.
  • In some cases, tumor removal did not alleviate mood or cognitive impairments.

Conclusions

  • Anxiety, depression, and cognitive changes show potential as early indicators for brain tumors.
  • These symptoms are influenced by tumor pathology and may not be fully resolved by surgical intervention.
  • Further research is warranted to validate these findings for clinical application in early brain tumor detection.